Sionna Therapeutics hopes to raise $150 million and secure a market capitalization of about $692 million in an initial public ...

Eleva, a German biopharmaceutical company, and 3PBIOVIAN, a global contract development and manufacturing organization (CDMO) ...

French drugmaker Mitem Pharma, which is dedicated to drugs of major therapeutic interest (DMTI), today revealed that has ...

Russia is experiencing a sharp growth in the demand for drugs against diabetes this year, particular those that are also used ...

US President Donald Trump has implemented a series of tariffs on imports from Canada, Mexico and China, but the additional ...

Japan’s ASKA Pharmaceutical Holdings announced it has decided to acquire additional shares of Vietnam-based Ha Tay ...

A Feature on M&A, VC investment licensing and partnerships focusing on novel targets in autoimmune diseases. The global ...

The market for Parkinson’s disease (PD) drugs across the seven major geographies (7MM; USA, France, Germany, Italy, UK and ...

I-Mab has laid off almost a third of its employees as part of a restructuring effort, the company disclosed in a recent ...

The company earlier announced that the primary endpoint was met in a randomized, double-blind, placebo-controlled Phase IIb ...

Chinese biotech company Vigonvita Life Sciences has filed for an initial public offering (IPO) on the Hong Kong Stock ...

US mRNA specialist Moderna demonstrated substantial R&D investment and progress in the UK, two years since signing its ...